Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

Introduction: Many studies have focused on the role of programmed death receptor ligand 1 (PD-L1) expression in predicting immunotherapy outcomes. Limited clinical data are available regarding the role of programmed death receptor 1 (PD-1; the PD-L1 receptor) expressing tumor-infiltrating lymphocyte...

Full description

Bibliographic Details
Main Authors: Nicholas J. Bevins, Ryosuke Okamura, Meagan Montesion, Jacob J. Adashek, Aaron M. Goodman, Razelle Kurzrock
Format: Article
Language:English
Published: Innovative Healthcare Institute 2022-11-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
immune checkpoint inhibition
tumor infiltrating lymphocyte
immunotherapy
Online Access:https://theijpt.org/doi/pdf/10.36401/JIPO-22-9

Internet

https://theijpt.org/doi/pdf/10.36401/JIPO-22-9

Similar Items